Literature DB >> 12125078

Effect of geranylgeranylaceton on cellular damage induced by proteasome inhibition in cultured spinal neurons.

Seiji Kikuchi1, Kazuyoshi Shinpo, Masayoshi Takeuchi, Sachiko Tsuji, Ichiro Yabe, Masaaki Niino, Kunio Tashiro.   

Abstract

We investigated the effect of two proteasome inhibitors, lactacystin and epoxomicin, on cultured spinal cord neurons. The incubation of spinal neurons with proteasome inhibitors for 24 hr induced neurotoxicity in a dose-dependent manner. We found motor neurons to be more vulnerable to proteasome-induced neurotoxicity than nonmotor neurons. The staining of cell bodies in treated motor neurons was markedly disrupted and showed characteristic granular patterns. Proteasome-induced neurotoxicity is accompanied by apoptotic nuclear changes, posttranslational modification of the cellular proteins, generation of intracellular free radicals, reduction in the amount of reduced glutathione, and mitochondrial dysfunction. Neurotoxicity was reduced by the administration of low concentrations (1-100 nM) of geranylgeranylacetone (GGA), which is widely used as an antiulcer drug, although higher concentrations of this drug produced neurotoxicity in spinal cord neurons. GGA was found to induce the expression of heat shock protein 70 as well as thioredoxin, which may partly contribute to the protective effect of GGA. These data suggest that the inhibition of proteasome may play a role in the mechanism of neurodegenerative diseases of the spinal cord, such as amyotrophic lateral sclerosis, and that the use of GGA may be effective in the treatment of these conditions. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12125078     DOI: 10.1002/jnr.10298

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

Review 1.  The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.

Authors:  Mario Di Napoli; BethAnn McLaughlin
Journal:  Curr Opin Investig Drugs       Date:  2005-07

2.  Mimetics of hormetic agents: stress-resistance triggers.

Authors:  Joan Smith Sonneborn
Journal:  Dose Response       Date:  2010-01-06       Impact factor: 2.658

3.  Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease.

Authors:  Masahisa Katsuno; Chen Sang; Hiroaki Adachi; Makoto Minamiyama; Masahiro Waza; Fumiaki Tanaka; Manabu Doyu; Gen Sobue
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

4.  Loss of hsp70.1 Decreases Functional Motor Recovery after Spinal Cord Injury in Mice.

Authors:  Hyun Jeong Kim; Ji-In Jung; Youngkyung Kim; Jae-Seon Lee; Young Wook Yoon; Junesun Kim
Journal:  Korean J Physiol Pharmacol       Date:  2010-06-30       Impact factor: 2.016

5.  HSP70 protects rats and hippocampal neurons from central nervous system oxygen toxicity by suppression of NO production and NF-κB activation.

Authors:  Hongjie Yi; Guoyang Huang; Kun Zhang; Shulin Liu; Weigang Xu
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

Review 6.  The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord Injury.

Authors:  Bing Gong; Miroslav Radulovic; Maria E Figueiredo-Pereira; Christopher Cardozo
Journal:  Front Mol Neurosci       Date:  2016-01-26       Impact factor: 5.639

7.  Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.

Authors:  Kelley Salem; Michael L McCormick; Erik Wendlandt; Fenghuang Zhan; Apollina Goel
Journal:  Redox Biol       Date:  2014-11-18       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.